Products

ABRAXANE^® (nanoparticle albumin-bound paclitaxel) is used for the treatment of patients with:

• Metastatic breast cancer
• Non-small cell lung cancer, in combination with another cancer medicine, carboplatin
• Metastatic pancreatic cancer, in combination with another cancer medicine, gemcitabine

ABRAXANE Product Information (Australia)

ABRAXANE Data Sheet (New Zealand)

ABRAXANE Consumer Medicine Information

ABRAXANE Safety Data Sheet

Pancreatic Cancer - Disease Fact Sheet

NERLYNX^® (neratinib)is TGA approved for the extended adjuvant treatment of adult patients with early-stage HER2-overexpressed / amplified breast cancer, to follow adjuvant trastuzumab based therapy.

NERLYNX Product Information

NERLYNX Consumer Medicine Information

ICLUSIG^® (ponatinib HCl) is used to treat adults with chronic myeloid leukaemia (CML) or Philadelphia-chromosome positive acute lymphoblastic leukaemia (Ph+ ALL) who are no longer benefiting from treatment with other medicines.

ICLUSIG Product Information

ICLUSIG Consumer Medicine Information

Chronic Myeloid Leukaemia - Disease Fact Sheet

APLIDIN^® (plitidepsin) in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma.

APLIDIN Product Information

APLIDIN Consumer Medicine Information

APLIDIN Safety Data Sheet

Living with Multiple Myeloma: A Patient’s Story

GLIOLAN^® (aminolevulinic acid hydrochloride) is an orally administered drug used for the visualisation of certain brain tumours (called glioblastoma multiforme) during tumour surgery.

To view a brief video of fluorescence-guided glioma surgery using GLIOLAN, click here

GLIOLAN Product Information (Australia)

GLIOLAN Data Sheet (New Zealand)

GLIOLAN Consumer Medicine Information

GLIOLAN Safety Data Sheet

GLIOLAN Neurosurgeon Training Program

Gliolan Experienced User Meeting Video